Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia

✍ Scribed by Salma A. Abdalla; Urszula Cymerman; Diane Rushlow; Ning Chen; Gwendolyn P. Stoeber; Edmond G. Lemire; Michelle Letarte

• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 71 KB
• Volume: 25
• Category: Article
• ISSN: 1059-7794
• DOI: 10.1002/humu.9312

✦ Synopsis

Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant vascular disorder caused by mutations in Endoglin (ENG) or activin receptor-like kinase-1 (ALK1, ACVRL1)

genes. We performed molecular characterization in clinically affected probands of 31 HHT families and detected a total of 28 different mutations in the two genes, including four shared by more than one family. Twelve mutations were identified in the ENG gene, six of which were novel and comprised two nonsense mutations in exons 6 and 8, deletions in exons 5 and 11, and splice site mutations in exon 12 and intron 8. Eleven of sixteen mutations identified in the ALK1 gene were novel single base pair substitutions in exons 4, 7, 8, and 9. We also describe the first de novo ALK1 mutation that causes a previously unreported c.1133C>A substitution of a highly conserved residue (p.P378H). The proband and his two daughters, who also carried the familial mutation, all suffered from gastrointestinal (GI) bleeding. In addition, we report seven newly identified polymorphims and summarize all known ones in both genes.